Key facts
- Candid Health’s last known valuation is $250.0M (Jan 2025).
- It has raised $99.5M across 1 recorded rounds; the latest was Early Stage VC (Series B) ($29.0M) in Jun 2023.
- Notable investors include Y Combinator, Astir Ventures, BoxGroup, 8VC, First Round Capital — 13 tracked in total.
- Status: Privately Held (backing).
Leadership
- Bud McGannChief Commercial Officer
- Nicholas PerryCo-Founder and Chief Executive Officer
- Doug ProctorCo-Founder & Chief Operating Officer
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Candid Health
Funding rounds
1 roundsAbout Candid Health
Developer of a revenue cycle automation platform designed to make medical billing easy. The company's platform easily integrates with existing custom and commercial infrastructure and offers modern tools for managing the complexity of medical billing, enabling healthcare providers to focus on accessible care.
- Industry
- Other Healthcare Services
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2019
- Employees
- 164
- Website
- joincandidhealth.com/
- Ownership
- Privately Held (backing)
Candid Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Candid Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Candid Health in its N-PORT filings yet. We sweep new filings monthly.